» Articles » PMID: 17786053

Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution?

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2007 Sep 6
PMID 17786053
Citations 169
Authors
Affiliations
Soon will be listed here.
Abstract

Breast tumors are composed of a variety of cell types with distinct morphologies and behaviors. It is not clear how this tumor heterogeneity comes about. Two popular concepts that attempt to explain this are the cancer stem cell hypothesis and the clonal evolution model. Each of these ideas has been investigated for some time, leading to the accumulation of numerous findings that are used to support one or the other. Although the two views share some similarities, they are fundamentally different notions with very different clinical implications. Analysis of the research backing each concept, along with a review of the results of our recent study investigating putative breast cancer stem cells, suggests how the cancer stem cell hypothesis and the clonal evolution model may be involved in generating breast tumor heterogeneity. An understanding of this process will allow the development of more effective ways to treat and prevent breast cancer.

Citing Articles

Cellular Systems for Colorectal Stem Cancer Cell Research.

Grigoreva T, Kindt D, Sagaidak A, Novikova D, Tribulovich V Cells. 2025; 14(3).

PMID: 39936962 PMC: 11817814. DOI: 10.3390/cells14030170.


A Fungicide, Fludioxonil, Formed the Polyploid Giant Cancer Cells and Induced Metastasis and Stemness in MDA-MB-231 Triple-Negative Breast Cancer Cells.

Go R, Seong S, Choi Y, Choi K Int J Mol Sci. 2024; 25(16).

PMID: 39201710 PMC: 11354328. DOI: 10.3390/ijms25169024.


Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer.

Volmer L, Dannehl D, Matovina S, Taran F, Walter C, Wallwiener M Int J Mol Sci. 2024; 25(11).

PMID: 38892097 PMC: 11173203. DOI: 10.3390/ijms25115910.


Effects of CD44 siRNA on inhibition, survival, and apoptosis of breast cancer cell lines (MDA-MB-231 and 4T1).

Dehbokri S, Noorolyai S, Baghbani E, Moghaddamneshat N, Javaheri T, Baradaran B Mol Biol Rep. 2024; 51(1):646.

PMID: 38727931 DOI: 10.1007/s11033-024-09572-9.


RARRES2 is involved in the "lock-and-key" interactions between osteosarcoma stem cells and tumor-associated macrophages.

Ma J, Chen Z, Li Q, Wang L, Chen J, Yang X Sci Rep. 2024; 14(1):2267.

PMID: 38280909 PMC: 10821905. DOI: 10.1038/s41598-024-52738-5.